

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.86030553 |
| 2 | replication fork processing (GO:0031297) | 7.18353008 |
| 3 | transcription from mitochondrial promoter (GO:0006390) | 6.92037519 |
| 4 | embryonic process involved in female pregnancy (GO:0060136) | 6.83234629 |
| 5 | proline metabolic process (GO:0006560) | 6.66205510 |
| 6 | DNA deamination (GO:0045006) | 6.47887247 |
| 7 | positive regulation of protein homooligomerization (GO:0032464) | 6.41510984 |
| 8 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 6.32382391 |
| 9 | regulation of integrin activation (GO:0033623) | 5.48836845 |
| 10 | oxidative demethylation (GO:0070989) | 5.21313820 |
| 11 | DNA strand renaturation (GO:0000733) | 5.20546997 |
| 12 | regulation of protein homooligomerization (GO:0032462) | 5.09596289 |
| 13 | mitochondrial DNA metabolic process (GO:0032042) | 5.04590584 |
| 14 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.03324685 |
| 15 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.03324685 |
| 16 | poly(A)+ mRNA export from nucleus (GO:0016973) | 5.03253301 |
| 17 | establishment of apical/basal cell polarity (GO:0035089) | 4.88623957 |
| 18 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.57948450 |
| 19 | viral mRNA export from host cell nucleus (GO:0046784) | 4.55218857 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.33152162 |
| 21 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.29185843 |
| 22 | base-excision repair (GO:0006284) | 4.24193620 |
| 23 | DNA topological change (GO:0006265) | 4.22625384 |
| 24 | mRNA cleavage (GO:0006379) | 4.12473241 |
| 25 | establishment of monopolar cell polarity (GO:0061162) | 4.10217707 |
| 26 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.10217707 |
| 27 | mitotic G1/S transition checkpoint (GO:0044819) | 4.08997555 |
| 28 | G1 DNA damage checkpoint (GO:0044783) | 4.08617712 |
| 29 | cellular response to zinc ion (GO:0071294) | 4.06581485 |
| 30 | regulation of translational fidelity (GO:0006450) | 4.01418343 |
| 31 | embryonic placenta development (GO:0001892) | 4.01140346 |
| 32 | formation of translation preinitiation complex (GO:0001731) | 3.94723974 |
| 33 | meiotic chromosome segregation (GO:0045132) | 3.93454326 |
| 34 | negative regulation of mRNA processing (GO:0050686) | 3.89783185 |
| 35 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.89213716 |
| 36 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.88838896 |
| 37 | negative regulation of cell cycle arrest (GO:0071157) | 3.86859977 |
| 38 | dosage compensation (GO:0007549) | 3.84672861 |
| 39 | nuclear pore complex assembly (GO:0051292) | 3.82566738 |
| 40 | establishment of integrated proviral latency (GO:0075713) | 3.81442741 |
| 41 | positive regulation of protein oligomerization (GO:0032461) | 3.77208671 |
| 42 | positive regulation by host of viral transcription (GO:0043923) | 3.76795465 |
| 43 | ribosome assembly (GO:0042255) | 3.76591682 |
| 44 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.68600486 |
| 45 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.68600486 |
| 46 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.68600486 |
| 47 | DNA integration (GO:0015074) | 3.67147223 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.64694367 |
| 49 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.61623662 |
| 50 | DNA double-strand break processing (GO:0000729) | 3.60368009 |
| 51 | telomere maintenance via recombination (GO:0000722) | 3.56577874 |
| 52 | termination of RNA polymerase II transcription (GO:0006369) | 3.56072989 |
| 53 | nuclear pore organization (GO:0006999) | 3.53820384 |
| 54 | establishment of viral latency (GO:0019043) | 3.53749234 |
| 55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.53249848 |
| 56 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.53106652 |
| 57 | regulation of RNA export from nucleus (GO:0046831) | 3.52462575 |
| 58 | mitochondrial RNA metabolic process (GO:0000959) | 3.52143879 |
| 59 | negative regulation of RNA splicing (GO:0033119) | 3.51789961 |
| 60 | proteasome assembly (GO:0043248) | 3.51561204 |
| 61 | kinetochore assembly (GO:0051382) | 3.48294169 |
| 62 | histone H4-K12 acetylation (GO:0043983) | 3.47508159 |
| 63 | trophectodermal cell differentiation (GO:0001829) | 3.44876263 |
| 64 | face development (GO:0060324) | 3.44033168 |
| 65 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.41582405 |
| 66 | non-recombinational repair (GO:0000726) | 3.41582405 |
| 67 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.41359901 |
| 68 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.40098788 |
| 69 | cellular response to ATP (GO:0071318) | 3.39650612 |
| 70 | regulation of sister chromatid cohesion (GO:0007063) | 3.39470028 |
| 71 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.38894252 |
| 72 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.37517554 |
| 73 | DNA strand elongation (GO:0022616) | 3.33498744 |
| 74 | positive regulation of developmental pigmentation (GO:0048087) | 3.32778034 |
| 75 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.32381547 |
| 76 | negative regulation of ligase activity (GO:0051352) | 3.32178601 |
| 77 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.32178601 |
| 78 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.30346278 |
| 79 | regulation of protein oligomerization (GO:0032459) | 3.28611609 |
| 80 | regulation of DNA damage checkpoint (GO:2000001) | 3.24874981 |
| 81 | negative regulation of Ras GTPase activity (GO:0034261) | 3.22684793 |
| 82 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20498509 |
| 83 | negative regulation of protein oligomerization (GO:0032460) | 3.19357719 |
| 84 | DNA ligation (GO:0006266) | 3.19239371 |
| 85 | base-excision repair, AP site formation (GO:0006285) | 3.18497244 |
| 86 | resolution of meiotic recombination intermediates (GO:0000712) | 3.15741762 |
| 87 | negative regulation of mRNA metabolic process (GO:1903312) | 3.15374430 |
| 88 | spliceosomal snRNP assembly (GO:0000387) | 3.15222980 |
| 89 | apoptotic process involved in morphogenesis (GO:0060561) | 3.12952524 |
| 90 | embryonic camera-type eye development (GO:0031076) | 3.12790223 |
| 91 | regulation of mitochondrial translation (GO:0070129) | 3.12274724 |
| 92 | tRNA methylation (GO:0030488) | 3.11683697 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10841985 |
| 94 | kinetochore organization (GO:0051383) | 3.10827668 |
| 95 | positive regulation of chromosome segregation (GO:0051984) | 3.10325989 |
| 96 | mitotic recombination (GO:0006312) | 3.10317086 |
| 97 | maturation of 5.8S rRNA (GO:0000460) | 3.09801966 |
| 98 | mitotic nuclear envelope disassembly (GO:0007077) | 3.07604078 |
| 99 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.06645341 |
| 100 | histone arginine methylation (GO:0034969) | 3.05467163 |
| 101 | telomere maintenance via telomere lengthening (GO:0010833) | 3.04140044 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 3.02668544 |
| 103 | peptidyl-arginine N-methylation (GO:0035246) | 3.02349278 |
| 104 | peptidyl-arginine methylation (GO:0018216) | 3.02349278 |
| 105 | regulation of double-strand break repair (GO:2000779) | 3.02164927 |
| 106 | pore complex assembly (GO:0046931) | 3.01336312 |
| 107 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.01112740 |
| 108 | mitotic metaphase plate congression (GO:0007080) | 3.00050901 |
| 109 | ribosome biogenesis (GO:0042254) | 2.99574738 |
| 110 | nuclear envelope disassembly (GO:0051081) | 2.97613096 |
| 111 | membrane disassembly (GO:0030397) | 2.97613096 |
| 112 | mitotic chromosome condensation (GO:0007076) | 2.97155366 |
| 113 | DNA demethylation (GO:0080111) | 2.97126580 |
| 114 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.94158606 |
| 115 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.93980738 |
| 116 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.93980738 |
| 117 | mitotic sister chromatid segregation (GO:0000070) | 2.93519236 |
| 118 | negative regulation of interleukin-12 production (GO:0032695) | 2.92515114 |
| 119 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.91217369 |
| 120 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.89323661 |
| 121 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.89323661 |
| 122 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.89323661 |
| 123 | determination of adult lifespan (GO:0008340) | 2.88657600 |
| 124 | de novo protein folding (GO:0006458) | 2.87177404 |
| 125 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.86100051 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.86100051 |
| 127 | mitochondrial DNA replication (GO:0006264) | 2.85354173 |
| 128 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.84356032 |
| 129 | mRNA export from nucleus (GO:0006406) | 2.83065630 |
| 130 | de novo posttranslational protein folding (GO:0051084) | 2.82502486 |
| 131 | maturation of SSU-rRNA (GO:0030490) | 2.82333622 |
| 132 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.82197403 |
| 133 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.81034646 |
| 134 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.78928149 |
| 135 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.77903399 |
| 136 | regulation of gene silencing by miRNA (GO:0060964) | 2.77903399 |
| 137 | regulation of gene silencing by RNA (GO:0060966) | 2.77903399 |
| 138 | positive regulation of granulocyte differentiation (GO:0030854) | 2.77642831 |
| 139 | IMP biosynthetic process (GO:0006188) | 2.77569290 |
| 140 | nodal signaling pathway (GO:0038092) | 2.75747981 |
| 141 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.75374044 |
| 142 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.74446961 |
| 143 | V(D)J recombination (GO:0033151) | 2.74099358 |
| 144 | positive regulation of ligase activity (GO:0051351) | 2.74083484 |
| 145 | somatic cell DNA recombination (GO:0016444) | 2.73708952 |
| 146 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.73708952 |
| 147 | DNA damage response, detection of DNA damage (GO:0042769) | 2.73667914 |
| 148 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.72692125 |
| 149 | protein targeting to mitochondrion (GO:0006626) | 2.72569649 |
| 150 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.70347694 |
| 151 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.68850801 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68257203 |
| 153 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.67955606 |
| 154 | rRNA modification (GO:0000154) | 2.65206114 |
| 155 | ribosomal large subunit biogenesis (GO:0042273) | 2.64893628 |
| 156 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.63925447 |
| 157 | negative regulation of chromosome segregation (GO:0051985) | 2.61400511 |
| 158 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.59370640 |
| 159 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.59370640 |
| 160 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.59370640 |
| 161 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.59370640 |
| 162 | negative regulation of sister chromatid segregation (GO:0033046) | 2.59370640 |
| 163 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.58041100 |
| 164 | establishment of protein localization to mitochondrion (GO:0072655) | 2.57120060 |
| 165 | rRNA transcription (GO:0009303) | 2.56428890 |
| 166 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.56336815 |
| 167 | protein localization to mitochondrion (GO:0070585) | 2.56324911 |
| 168 | mitotic spindle assembly checkpoint (GO:0007094) | 2.56277460 |
| 169 | regulation of ligase activity (GO:0051340) | 2.55324159 |
| 170 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.54176334 |
| 171 | mRNA splicing, via spliceosome (GO:0000398) | 2.52014496 |
| 172 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.52014496 |
| 173 | regulation of translation in response to stress (GO:0043555) | 2.51699175 |
| 174 | rRNA processing (GO:0006364) | 2.50168950 |
| 175 | DNA unwinding involved in DNA replication (GO:0006268) | 2.49868607 |
| 176 | RNA splicing, via transesterification reactions (GO:0000375) | 2.49415049 |
| 177 | rRNA methylation (GO:0031167) | 2.49214247 |
| 178 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49145683 |
| 179 | protein localization to chromosome, centromeric region (GO:0071459) | 2.48980654 |
| 180 | nuclear envelope organization (GO:0006998) | 2.48810615 |
| 181 | spindle assembly checkpoint (GO:0071173) | 2.47976022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.62058401 |
| 2 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.68042569 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.23695566 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.06443734 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.00900324 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92620426 |
| 7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.89976054 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.78579348 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.77360647 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.73950079 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.70518565 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.51446351 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46132597 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.42417513 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29909150 |
| 16 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.27581073 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25841230 |
| 18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.23781115 |
| 19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.23781115 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.23781115 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.23750992 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.12762308 |
| 23 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.10651536 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06819635 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.03487444 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01168235 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89618504 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.86691741 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.85063150 |
| 30 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.83950526 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.81938028 |
| 32 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.79580629 |
| 33 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.77759267 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77115061 |
| 35 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.77056281 |
| 36 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.73363778 |
| 37 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.71220351 |
| 38 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.67988630 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.67673468 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67225134 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66487594 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65132152 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64251567 |
| 44 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62369549 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60777873 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60716582 |
| 47 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.60085610 |
| 48 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54594118 |
| 49 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.53817073 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53363842 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.52948110 |
| 52 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.52312065 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51863409 |
| 54 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49932011 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48689276 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46319840 |
| 57 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45624788 |
| 58 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.44815347 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44610594 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43665594 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43320393 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43167594 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40883785 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40090784 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38780312 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38770095 |
| 67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37874135 |
| 68 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.35132639 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.34626099 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33799308 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33773936 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32747543 |
| 73 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32271598 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31253590 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30891322 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30845458 |
| 77 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30519181 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30162861 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30046218 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29485730 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28573451 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28485412 |
| 83 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28347744 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28094423 |
| 85 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27840031 |
| 86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27409234 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26947587 |
| 88 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26941925 |
| 89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26908163 |
| 90 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25887174 |
| 91 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25758138 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25716889 |
| 93 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.25609751 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25042262 |
| 95 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24515177 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23672144 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23112778 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22843872 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22428682 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22241959 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19234011 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19124137 |
| 103 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18893111 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18543472 |
| 105 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18330129 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18223990 |
| 107 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18129915 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17084019 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17014107 |
| 110 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.15120675 |
| 111 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14319327 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 1.14154306 |
| 113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14127827 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13474240 |
| 115 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12982023 |
| 116 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12917955 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.12716071 |
| 118 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.11443017 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11157904 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10085923 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09869156 |
| 122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09130455 |
| 123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08259126 |
| 124 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.08235670 |
| 125 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08149341 |
| 126 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.07418279 |
| 127 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.06862124 |
| 128 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06858129 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06125595 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05952317 |
| 131 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04272737 |
| 132 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02710118 |
| 133 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02427540 |
| 134 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02097965 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02038856 |
| 136 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01317760 |
| 137 | MYB_26560356_Chip-Seq_TH1_Human | 1.01268316 |
| 138 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.00875506 |
| 139 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00485920 |
| 140 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99202424 |
| 141 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97975883 |
| 142 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.97098632 |
| 143 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.94932913 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88601548 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86395777 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86289605 |
| 147 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86035233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.87574576 |
| 2 | MP0009278_abnormal_bone_marrow | 4.37609135 |
| 3 | MP0008260_abnormal_autophagy | 3.23091965 |
| 4 | MP0002009_preneoplasia | 3.14670233 |
| 5 | MP0005171_absent_coat_pigmentation | 3.09125934 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.05277790 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 2.56056917 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.56056917 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.50709305 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.40964168 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.35739026 |
| 12 | MP0008995_early_reproductive_senescence | 2.34041486 |
| 13 | MP0008058_abnormal_DNA_repair | 2.26829401 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.24626171 |
| 15 | MP0003693_abnormal_embryo_hatching | 2.14623004 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.12883207 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 2.12359167 |
| 18 | MP0001853_heart_inflammation | 2.12227075 |
| 19 | MP0005451_abnormal_body_composition | 2.09847574 |
| 20 | MP0003436_decreased_susceptibility_to | 2.05732198 |
| 21 | MP0000685_abnormal_immune_system | 2.00333816 |
| 22 | MP0003786_premature_aging | 1.98824297 |
| 23 | MP0004233_abnormal_muscle_weight | 1.96846479 |
| 24 | MP0003077_abnormal_cell_cycle | 1.93985479 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.87529712 |
| 26 | MP0001348_abnormal_lacrimal_gland | 1.84064706 |
| 27 | MP0000490_abnormal_crypts_of | 1.83381488 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.77562076 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.71203428 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.66975788 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.62232853 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.61546868 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.58805123 |
| 34 | MP0002086_abnormal_extraembryonic_tissu | 1.58542604 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.58483003 |
| 36 | MP0000371_diluted_coat_color | 1.56523813 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49513834 |
| 38 | MP0002405_respiratory_system_inflammati | 1.48263646 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.46455231 |
| 40 | MP0008789_abnormal_olfactory_epithelium | 1.45167003 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.42237460 |
| 42 | MP0001697_abnormal_embryo_size | 1.42198867 |
| 43 | MP0005671_abnormal_response_to | 1.41599794 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.41043059 |
| 45 | MP0001293_anophthalmia | 1.40556530 |
| 46 | MP0009697_abnormal_copulation | 1.39797033 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.37827477 |
| 48 | MP0005499_abnormal_olfactory_system | 1.37741529 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.37741529 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.36992141 |
| 51 | MP0002084_abnormal_developmental_patter | 1.36849574 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.36767469 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.36257142 |
| 54 | MP0010307_abnormal_tumor_latency | 1.34522581 |
| 55 | MP0004133_heterotaxia | 1.34172732 |
| 56 | MP0003119_abnormal_digestive_system | 1.33562057 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.32762128 |
| 58 | MP0006082_CNS_inflammation | 1.32455876 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.31296699 |
| 60 | MP0004197_abnormal_fetal_growth/weight/ | 1.31075819 |
| 61 | MP0000358_abnormal_cell_content/ | 1.29433759 |
| 62 | MP0001672_abnormal_embryogenesis/_devel | 1.28299766 |
| 63 | MP0005380_embryogenesis_phenotype | 1.28299766 |
| 64 | MP0001727_abnormal_embryo_implantation | 1.28069619 |
| 65 | MP0004947_skin_inflammation | 1.27998847 |
| 66 | MP0002085_abnormal_embryonic_tissue | 1.27828632 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.27631905 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.27449196 |
| 69 | MP0000350_abnormal_cell_proliferation | 1.25918451 |
| 70 | MP0002398_abnormal_bone_marrow | 1.24550601 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.22246402 |
| 72 | MP0000470_abnormal_stomach_morphology | 1.15040946 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.13963707 |
| 74 | MP0003828_pulmonary_edema | 1.13211182 |
| 75 | MP0001730_embryonic_growth_arrest | 1.11615407 |
| 76 | MP0002722_abnormal_immune_system | 1.10338872 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.10038841 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.09232165 |
| 79 | MP0009840_abnormal_foam_cell | 1.08318093 |
| 80 | MP0002249_abnormal_larynx_morphology | 1.08291027 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.07044017 |
| 82 | MP0003283_abnormal_digestive_organ | 1.06600120 |
| 83 | MP0002006_tumorigenesis | 1.06113649 |
| 84 | MP0000313_abnormal_cell_death | 1.05037989 |
| 85 | MP0002254_reproductive_system_inflammat | 1.03564343 |
| 86 | MP0000858_altered_metastatic_potential | 1.02019541 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 1.01737536 |
| 88 | MP0003984_embryonic_growth_retardation | 1.00799873 |
| 89 | MP0002419_abnormal_innate_immunity | 1.00771052 |
| 90 | MP0005384_cellular_phenotype | 1.00363541 |
| 91 | MP0002080_prenatal_lethality | 1.00146325 |
| 92 | MP0005025_abnormal_response_to | 0.98918478 |
| 93 | MP0002088_abnormal_embryonic_growth/wei | 0.97971434 |
| 94 | MP0002075_abnormal_coat/hair_pigmentati | 0.97888883 |
| 95 | MP0002132_abnormal_respiratory_system | 0.97726232 |
| 96 | MP0001529_abnormal_vocalization | 0.96783943 |
| 97 | MP0001800_abnormal_humoral_immune | 0.96250762 |
| 98 | MP0000579_abnormal_nail_morphology | 0.95977352 |
| 99 | MP0003186_abnormal_redox_activity | 0.95660006 |
| 100 | MP0010155_abnormal_intestine_physiology | 0.93807210 |
| 101 | MP0005621_abnormal_cell_physiology | 0.93426563 |
| 102 | MP0001873_stomach_inflammation | 0.92810766 |
| 103 | MP0000716_abnormal_immune_system | 0.89552757 |
| 104 | MP0002796_impaired_skin_barrier | 0.87958158 |
| 105 | MP0002429_abnormal_blood_cell | 0.87520491 |
| 106 | MP0002111_abnormal_tail_morphology | 0.86312865 |
| 107 | MP0005408_hypopigmentation | 0.86083885 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.83709142 |
| 109 | MP0009115_abnormal_fat_cell | 0.83440769 |
| 110 | MP0001835_abnormal_antigen_presentation | 0.83299407 |
| 111 | MP0001186_pigmentation_phenotype | 0.82406999 |
| 112 | MP0002210_abnormal_sex_determination | 0.82317063 |
| 113 | MP0002060_abnormal_skin_morphology | 0.81820233 |
| 114 | MP0003045_fibrosis | 0.81736767 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.81510800 |
| 116 | MP0001915_intracranial_hemorrhage | 0.81468436 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.80638257 |
| 118 | MP0005310_abnormal_salivary_gland | 0.80086121 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.79737193 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.76650659 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.75760220 |
| 122 | MP0002269_muscular_atrophy | 0.74504815 |
| 123 | MP0003718_maternal_effect | 0.74259397 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.73792684 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.73710740 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.73602194 |
| 127 | MP0003699_abnormal_female_reproductive | 0.73186605 |
| 128 | MP0002723_abnormal_immune_serum | 0.71678843 |
| 129 | MP0001919_abnormal_reproductive_system | 0.71183275 |
| 130 | MP0001340_abnormal_eyelid_morphology | 0.71150245 |
| 131 | MP0001145_abnormal_male_reproductive | 0.70614923 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.70333200 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.70322868 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.70277367 |
| 135 | MP0008469_abnormal_protein_level | 0.69958455 |
| 136 | MP0005501_abnormal_skin_physiology | 0.69597981 |
| 137 | MP0000598_abnormal_liver_morphology | 0.69473219 |
| 138 | MP0002420_abnormal_adaptive_immunity | 0.69246410 |
| 139 | MP0001819_abnormal_immune_cell | 0.69183221 |
| 140 | MP0005365_abnormal_bile_salt | 0.67802390 |
| 141 | MP0001790_abnormal_immune_system | 0.66777631 |
| 142 | MP0005387_immune_system_phenotype | 0.66777631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.81487967 |
| 2 | Rib fusion (HP:0000902) | 4.84760813 |
| 3 | Facial hemangioma (HP:0000329) | 4.81241936 |
| 4 | Poikiloderma (HP:0001029) | 4.75089199 |
| 5 | Increased IgM level (HP:0003496) | 4.74428072 |
| 6 | Rectovaginal fistula (HP:0000143) | 4.31890621 |
| 7 | Rectal fistula (HP:0100590) | 4.31890621 |
| 8 | Concave nail (HP:0001598) | 4.28518444 |
| 9 | Annular pancreas (HP:0001734) | 4.11180980 |
| 10 | Intestinal fistula (HP:0100819) | 4.10118546 |
| 11 | Microvesicular hepatic steatosis (HP:0001414) | 4.06861685 |
| 12 | Alopecia of scalp (HP:0002293) | 3.87674506 |
| 13 | Vaginal fistula (HP:0004320) | 3.87121416 |
| 14 | Turricephaly (HP:0000262) | 3.86385728 |
| 15 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.84077637 |
| 16 | Ulnar bowing (HP:0003031) | 3.82184759 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.69509583 |
| 18 | Tongue fasciculations (HP:0001308) | 3.57946286 |
| 19 | Squamous cell carcinoma (HP:0002860) | 3.51099749 |
| 20 | Absent radius (HP:0003974) | 3.31704843 |
| 21 | Abnormality of male internal genitalia (HP:0000022) | 3.30729225 |
| 22 | Intestinal atresia (HP:0011100) | 3.29579808 |
| 23 | Absent thumb (HP:0009777) | 3.22613838 |
| 24 | Basal cell carcinoma (HP:0002671) | 3.20911836 |
| 25 | Muscle fibrillation (HP:0010546) | 3.18834738 |
| 26 | Short humerus (HP:0005792) | 3.15703152 |
| 27 | Albinism (HP:0001022) | 3.14892579 |
| 28 | Premature ovarian failure (HP:0008209) | 3.14648880 |
| 29 | IgA deficiency (HP:0002720) | 3.12254668 |
| 30 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.10905516 |
| 31 | Absent forearm bone (HP:0003953) | 3.10558858 |
| 32 | Aplasia involving forearm bones (HP:0009822) | 3.10558858 |
| 33 | Aplastic anemia (HP:0001915) | 3.09131231 |
| 34 | Male infertility (HP:0003251) | 3.02954575 |
| 35 | Hypochromic anemia (HP:0001931) | 3.02521581 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 3.00240926 |
| 37 | Rough bone trabeculation (HP:0100670) | 2.95099825 |
| 38 | Coronal craniosynostosis (HP:0004440) | 2.95056159 |
| 39 | Patellar aplasia (HP:0006443) | 2.91200980 |
| 40 | Orthostatic hypotension (HP:0001278) | 2.88369408 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.85768365 |
| 42 | Anteriorly placed anus (HP:0001545) | 2.83549788 |
| 43 | Multiple enchondromatosis (HP:0005701) | 2.82415540 |
| 44 | Selective tooth agenesis (HP:0001592) | 2.81301370 |
| 45 | Cholecystitis (HP:0001082) | 2.80626570 |
| 46 | Abnormal gallbladder physiology (HP:0012438) | 2.80626570 |
| 47 | Premature graying of hair (HP:0002216) | 2.80329993 |
| 48 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.79863166 |
| 49 | Vertebral hypoplasia (HP:0008417) | 2.79863166 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.78067952 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78067952 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.76961655 |
| 53 | Broad alveolar ridges (HP:0000187) | 2.74681980 |
| 54 | Abnormal hemoglobin (HP:0011902) | 2.70586901 |
| 55 | Cortical dysplasia (HP:0002539) | 2.69314968 |
| 56 | Secondary amenorrhea (HP:0000869) | 2.68139802 |
| 57 | Combined immunodeficiency (HP:0005387) | 2.67844928 |
| 58 | Short chin (HP:0000331) | 2.65472200 |
| 59 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.64563369 |
| 60 | Entropion (HP:0000621) | 2.63380168 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.57934077 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55877262 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55877262 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55877262 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.54689020 |
| 66 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.53271019 |
| 67 | Cellular immunodeficiency (HP:0005374) | 2.52473773 |
| 68 | Pelvic girdle muscle weakness (HP:0003749) | 2.51602450 |
| 69 | Volvulus (HP:0002580) | 2.51236094 |
| 70 | Severe combined immunodeficiency (HP:0004430) | 2.50648706 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.50619944 |
| 72 | Polycythemia (HP:0001901) | 2.50336780 |
| 73 | Dysautonomia (HP:0002459) | 2.49850712 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49366127 |
| 75 | Hypoplastic pelvis (HP:0008839) | 2.47769314 |
| 76 | Abnormal number of incisors (HP:0011064) | 2.46659491 |
| 77 | Acute lymphatic leukemia (HP:0006721) | 2.46398677 |
| 78 | Shoulder girdle muscle weakness (HP:0003547) | 2.45955730 |
| 79 | Cutaneous melanoma (HP:0012056) | 2.45130762 |
| 80 | Congenital hip dislocation (HP:0001374) | 2.44948603 |
| 81 | Abnormality of DNA repair (HP:0003254) | 2.44907464 |
| 82 | Premature skin wrinkling (HP:0100678) | 2.43665319 |
| 83 | Fatigue (HP:0012378) | 2.43089142 |
| 84 | Hypotelorism (HP:0000601) | 2.42499861 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.41017463 |
| 86 | Colitis (HP:0002583) | 2.39912618 |
| 87 | Hypertensive crisis (HP:0100735) | 2.39343023 |
| 88 | Chromsome breakage (HP:0040012) | 2.38639623 |
| 89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.38523905 |
| 90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.38523905 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.38464270 |
| 92 | Progressive external ophthalmoplegia (HP:0000590) | 2.36627167 |
| 93 | Pancytopenia (HP:0001876) | 2.35290855 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 2.34747770 |
| 95 | Bifid uvula (HP:0000193) | 2.31226162 |
| 96 | Growth hormone excess (HP:0000845) | 2.30972997 |
| 97 | Large for gestational age (HP:0001520) | 2.30732212 |
| 98 | Alacrima (HP:0000522) | 2.30225354 |
| 99 | Capillary hemangiomas (HP:0005306) | 2.29443407 |
| 100 | Cerebral aneurysm (HP:0004944) | 2.27638149 |
| 101 | Respiratory difficulties (HP:0002880) | 2.26269867 |
| 102 | Joint stiffness (HP:0001387) | 2.26249350 |
| 103 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.26242844 |
| 104 | Cheilitis (HP:0100825) | 2.25094236 |
| 105 | Abnormal protein glycosylation (HP:0012346) | 2.24610837 |
| 106 | Abnormal glycosylation (HP:0012345) | 2.24610837 |
| 107 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.24610837 |
| 108 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.24610837 |
| 109 | Increased hepatocellular lipid droplets (HP:0006565) | 2.24403546 |
| 110 | Diaphragmatic weakness (HP:0009113) | 2.22561869 |
| 111 | Reticulocytopenia (HP:0001896) | 2.22324477 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.22088383 |
| 113 | Hamartoma (HP:0010566) | 2.20510871 |
| 114 | Hypotrichosis (HP:0001006) | 2.20354335 |
| 115 | Lymphopenia (HP:0001888) | 2.18718106 |
| 116 | Spinal muscular atrophy (HP:0007269) | 2.16976255 |
| 117 | Verrucae (HP:0200043) | 2.15176887 |
| 118 | Papilloma (HP:0012740) | 2.15176887 |
| 119 | Hepatosplenomegaly (HP:0001433) | 2.14355469 |
| 120 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.13056266 |
| 121 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.13056266 |
| 122 | Abnormality of the aortic arch (HP:0012303) | 2.12978512 |
| 123 | Obstructive lung disease (HP:0006536) | 2.11297717 |
| 124 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11297717 |
| 125 | Abnormality of T cell physiology (HP:0011840) | 2.10915433 |
| 126 | Seborrheic dermatitis (HP:0001051) | 2.09843059 |
| 127 | Vertebral fusion (HP:0002948) | 2.09696412 |
| 128 | Oral leukoplakia (HP:0002745) | 2.09626432 |
| 129 | Myelodysplasia (HP:0002863) | 2.08000508 |
| 130 | IgG deficiency (HP:0004315) | 2.06850430 |
| 131 | Increased number of teeth (HP:0011069) | 2.06373540 |
| 132 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06107287 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05810486 |
| 134 | Lymphoma (HP:0002665) | 2.05178179 |
| 135 | Bowing of the arm (HP:0006488) | 2.04029186 |
| 136 | Bowed forearm bones (HP:0003956) | 2.04029186 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 2.03677022 |
| 138 | Bone marrow hypocellularity (HP:0005528) | 2.03340512 |
| 139 | Aplasia of the musculature (HP:0100854) | 2.02572766 |
| 140 | Hypergonadotropic hypogonadism (HP:0000815) | 2.02532430 |
| 141 | Increased serum lactate (HP:0002151) | 2.01753410 |
| 142 | Short thumb (HP:0009778) | 2.01095232 |
| 143 | Abnormality of the ileum (HP:0001549) | 2.00195813 |
| 144 | Abnormality of the astrocytes (HP:0100707) | 1.98973820 |
| 145 | Astrocytoma (HP:0009592) | 1.98973820 |
| 146 | Abnormality of reticulocytes (HP:0004312) | 1.98907360 |
| 147 | Abnormality of the preputium (HP:0100587) | 1.98562399 |
| 148 | Gastrointestinal atresia (HP:0002589) | 1.97959478 |
| 149 | Lipid accumulation in hepatocytes (HP:0006561) | 1.97471359 |
| 150 | Hypoplasia of the radius (HP:0002984) | 1.94906964 |
| 151 | Horseshoe kidney (HP:0000085) | 1.94598900 |
| 152 | IgM deficiency (HP:0002850) | 1.94395674 |
| 153 | Neoplasm of the oral cavity (HP:0100649) | 1.93444766 |
| 154 | Recurrent viral infections (HP:0004429) | 1.92955368 |
| 155 | Upper limb muscle weakness (HP:0003484) | 1.92657618 |
| 156 | Death in infancy (HP:0001522) | 1.91607157 |
| 157 | Athetosis (HP:0002305) | 1.91047931 |
| 158 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90240016 |
| 159 | Myocardial infarction (HP:0001658) | 1.89415533 |
| 160 | Gastrointestinal inflammation (HP:0004386) | 1.89187964 |
| 161 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89113504 |
| 162 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.88991614 |
| 163 | Split hand (HP:0001171) | 1.88957315 |
| 164 | Inflammation of the large intestine (HP:0002037) | 1.88403045 |
| 165 | Reticulocytosis (HP:0001923) | 1.87815042 |
| 166 | Proximal placement of thumb (HP:0009623) | 1.87766717 |
| 167 | Recurrent fungal infections (HP:0002841) | 1.87733625 |
| 168 | Muscle fiber atrophy (HP:0100295) | 1.87695125 |
| 169 | Cutaneous photosensitivity (HP:0000992) | 1.85508100 |
| 170 | Lower limb hyperreflexia (HP:0002395) | 1.84657759 |
| 171 | Pallor (HP:0000980) | 1.83609825 |
| 172 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.83031017 |
| 173 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.83031017 |
| 174 | Choanal stenosis (HP:0000452) | 1.82918050 |
| 175 | Neoplasm of the pancreas (HP:0002894) | 1.82262826 |
| 176 | Granulocytopenia (HP:0001913) | 1.81518049 |
| 177 | Abnormal number of erythroid precursors (HP:0012131) | 1.80851195 |
| 178 | Clumsiness (HP:0002312) | 1.80513098 |
| 179 | Abnormality of the labia minora (HP:0012880) | 1.80441325 |
| 180 | Bulbar palsy (HP:0001283) | 1.79931798 |
| 181 | Teleangiectasia of the skin (HP:0100585) | 1.76291761 |
| 182 | Achilles tendon contracture (HP:0001771) | 1.74834505 |
| 183 | Optic nerve coloboma (HP:0000588) | 1.73187931 |
| 184 | Abnormality of glycolysis (HP:0004366) | 1.73167595 |
| 185 | Neutropenia (HP:0001875) | 1.72336063 |
| 186 | Increased serum pyruvate (HP:0003542) | 1.72227523 |
| 187 | Abnormality of T cells (HP:0002843) | 1.71879150 |
| 188 | Deep palmar crease (HP:0006191) | 1.71263969 |
| 189 | Dysphonia (HP:0001618) | 1.69983589 |
| 190 | Trismus (HP:0000211) | 1.69805824 |
| 191 | Cholelithiasis (HP:0001081) | 1.69752755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 5.42617399 |
| 2 | MAPK15 | 4.43954550 |
| 3 | MAP3K6 | 4.26349809 |
| 4 | DDR2 | 4.03222715 |
| 5 | SRPK1 | 3.51905072 |
| 6 | TESK2 | 3.46894144 |
| 7 | PBK | 3.34476159 |
| 8 | MAP3K11 | 3.28002242 |
| 9 | PINK1 | 2.78955559 |
| 10 | MATK | 2.69802917 |
| 11 | FGR | 2.65869708 |
| 12 | PIM2 | 2.47099841 |
| 13 | TYRO3 | 2.43579071 |
| 14 | YES1 | 2.42090776 |
| 15 | CSK | 2.38989433 |
| 16 | BMX | 2.18326755 |
| 17 | DAPK1 | 2.04181108 |
| 18 | PRKD2 | 2.01540248 |
| 19 | UHMK1 | 1.98885538 |
| 20 | MAP3K10 | 1.98089095 |
| 21 | DYRK1B | 1.91838618 |
| 22 | CDK7 | 1.88794720 |
| 23 | PIM1 | 1.85698717 |
| 24 | BCKDK | 1.81745908 |
| 25 | SCYL2 | 1.81151005 |
| 26 | VRK2 | 1.73815579 |
| 27 | PDGFRA | 1.67137285 |
| 28 | SIK3 | 1.62452063 |
| 29 | TRPM7 | 1.62227366 |
| 30 | EIF2AK1 | 1.60434987 |
| 31 | CDK6 | 1.52208437 |
| 32 | MAP3K13 | 1.44083937 |
| 33 | MAP4K1 | 1.43944408 |
| 34 | NME1 | 1.36311466 |
| 35 | RPS6KC1 | 1.34851856 |
| 36 | RPS6KL1 | 1.34851856 |
| 37 | KDR | 1.31368168 |
| 38 | TSSK6 | 1.30771087 |
| 39 | NEK1 | 1.30430184 |
| 40 | DYRK3 | 1.30295793 |
| 41 | MAP3K14 | 1.29783652 |
| 42 | NEK2 | 1.29741483 |
| 43 | PDK2 | 1.27691856 |
| 44 | CHEK2 | 1.25280239 |
| 45 | RPS6KA6 | 1.23641482 |
| 46 | CDK12 | 1.23137711 |
| 47 | AKT3 | 1.22335980 |
| 48 | MAPK11 | 1.22156074 |
| 49 | TESK1 | 1.21900642 |
| 50 | MAP3K8 | 1.18077940 |
| 51 | IRAK3 | 1.16108861 |
| 52 | MAP2K3 | 1.15590381 |
| 53 | ERN1 | 1.12035153 |
| 54 | RPS6KA4 | 1.11587672 |
| 55 | CDK19 | 1.10741676 |
| 56 | MAP2K2 | 1.10420767 |
| 57 | IRAK4 | 1.09863279 |
| 58 | SMG1 | 1.09334474 |
| 59 | CLK1 | 1.08954690 |
| 60 | ATR | 1.04679084 |
| 61 | PLK1 | 1.01350181 |
| 62 | BCR | 1.00979423 |
| 63 | GSK3A | 1.00170657 |
| 64 | CDK8 | 0.99412733 |
| 65 | MAP2K7 | 0.98935038 |
| 66 | ARAF | 0.95430889 |
| 67 | PAK4 | 0.92060026 |
| 68 | MST1R | 0.91590466 |
| 69 | MARK3 | 0.90613238 |
| 70 | HIPK2 | 0.89431043 |
| 71 | TBK1 | 0.88490601 |
| 72 | TAOK2 | 0.82579263 |
| 73 | CDC42BPA | 0.82489379 |
| 74 | RPS6KA1 | 0.81462637 |
| 75 | CDC7 | 0.80494319 |
| 76 | MTOR | 0.80469304 |
| 77 | IKBKE | 0.75916365 |
| 78 | LATS2 | 0.73869059 |
| 79 | CDK4 | 0.73728341 |
| 80 | BRAF | 0.70767363 |
| 81 | IKBKB | 0.70284913 |
| 82 | FES | 0.69717393 |
| 83 | LYN | 0.69413343 |
| 84 | MST4 | 0.68963555 |
| 85 | PAK1 | 0.67521694 |
| 86 | ERBB4 | 0.66024397 |
| 87 | EPHB1 | 0.64415808 |
| 88 | VRK1 | 0.64377308 |
| 89 | PRPF4B | 0.63835689 |
| 90 | PLK4 | 0.62520670 |
| 91 | EIF2AK3 | 0.62398783 |
| 92 | STK3 | 0.61981895 |
| 93 | CSNK1A1L | 0.61920283 |
| 94 | CDK2 | 0.61003512 |
| 95 | STK10 | 0.60671667 |
| 96 | TRIB3 | 0.60017073 |
| 97 | NME2 | 0.59650881 |
| 98 | MOS | 0.59562597 |
| 99 | PRKAA1 | 0.58490024 |
| 100 | CSNK1G3 | 0.57984910 |
| 101 | AURKB | 0.57836253 |
| 102 | BUB1 | 0.57823298 |
| 103 | CCNB1 | 0.57532969 |
| 104 | WEE1 | 0.57499423 |
| 105 | RPS6KB2 | 0.56007274 |
| 106 | SIK2 | 0.55224596 |
| 107 | CHEK1 | 0.54230360 |
| 108 | RIPK4 | 0.53918631 |
| 109 | EIF2AK2 | 0.53353845 |
| 110 | BLK | 0.49732206 |
| 111 | TTK | 0.49321473 |
| 112 | CHUK | 0.49282765 |
| 113 | LCK | 0.49207771 |
| 114 | ALK | 0.47689354 |
| 115 | ZAP70 | 0.47502593 |
| 116 | MAP3K5 | 0.47439038 |
| 117 | TNK2 | 0.47039565 |
| 118 | ATM | 0.46468111 |
| 119 | TYK2 | 0.46209234 |
| 120 | FGFR4 | 0.45958298 |
| 121 | EGFR | 0.45866048 |
| 122 | CSNK2A1 | 0.44869618 |
| 123 | RPS6KB1 | 0.44506370 |
| 124 | PDGFRB | 0.43972517 |
| 125 | TRIM28 | 0.43639574 |
| 126 | MAPK3 | 0.43367710 |
| 127 | BRSK1 | 0.43069947 |
| 128 | FLT3 | 0.42483810 |
| 129 | MAPKAPK2 | 0.41097817 |
| 130 | MAPK1 | 0.40685732 |
| 131 | AURKA | 0.40153355 |
| 132 | MAPK4 | 0.39915870 |
| 133 | RAF1 | 0.39857527 |
| 134 | JAK3 | 0.39532131 |
| 135 | DYRK2 | 0.38130764 |
| 136 | MAPK14 | 0.33852940 |
| 137 | CDK1 | 0.32086244 |
| 138 | CSNK2A2 | 0.31660251 |
| 139 | TAOK1 | 0.30670029 |
| 140 | TLK1 | 0.30179437 |
| 141 | BRD4 | 0.29811728 |
| 142 | BTK | 0.28994332 |
| 143 | STK4 | 0.28873421 |
| 144 | EEF2K | 0.28655125 |
| 145 | CSNK1G1 | 0.28208291 |
| 146 | TXK | 0.27507194 |
| 147 | GRK6 | 0.26725638 |
| 148 | PHKG1 | 0.26201383 |
| 149 | PHKG2 | 0.26201383 |
| 150 | RIPK1 | 0.25626133 |
| 151 | PRKAA2 | 0.25609556 |
| 152 | ABL1 | 0.24844886 |
| 153 | MAPK10 | 0.24287441 |
| 154 | AKT1 | 0.23695586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 4.81259045 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 4.52938357 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.17446959 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.82283724 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.71412466 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56740137 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.47599732 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43533666 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.41023793 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.38156655 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.21327923 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.12502292 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.04813493 |
| 14 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.99543592 |
| 15 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.89920517 |
| 16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.78310876 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.75910400 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.66689630 |
| 19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64351911 |
| 20 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.62586643 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.57140743 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38336285 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29923270 |
| 24 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.26049927 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24312189 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22365422 |
| 27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20905523 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.16320169 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16216120 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15674853 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14607269 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.14402884 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13607841 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.13201855 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10677353 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08891968 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.08705878 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.07950508 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03618034 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.01411130 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98312465 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95858068 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95245496 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94063114 |
| 45 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.93897740 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.93587954 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93116265 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92977402 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.92833183 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91358716 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91311005 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89114877 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85223410 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84312797 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83566485 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83318770 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81612273 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80941886 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80812448 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80527453 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79392351 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79364003 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79037869 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.78451523 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77949509 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77662987 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76245071 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75787606 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75284470 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74648064 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73962476 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.73619966 |
| 73 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73605211 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.72565613 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.72042373 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72016944 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71355659 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.71222470 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69694573 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69684398 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.69511048 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68908021 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68050228 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67829689 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67032835 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66157449 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65262975 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64234548 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63985256 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63530024 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62259102 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.61925498 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60968548 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60405714 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.59746314 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57309137 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57227612 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55122560 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54537152 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54323839 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54137951 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52989218 |
| 103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52898260 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52328632 |
| 105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52030846 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50163588 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49167144 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49075702 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.48870792 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48830740 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48387850 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.48210964 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47526369 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46214358 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45436440 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45352286 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45200409 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45184146 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43838051 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41722536 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41520412 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39397067 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39388603 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38980626 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38708175 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38104839 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38031232 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37707966 |
| 129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37433649 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36990965 |
| 131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36075538 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35698003 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33581158 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31451006 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.30988503 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28932164 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27826170 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27791497 |
| 139 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27197618 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26326986 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26065392 |
| 142 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25751564 |

